Suppliers / Shanghai Desano Chemical Pharmaceutical

Shanghai Desano Chemical Pharmaceutical

China Updated 9 July 2026

Shanghai Desano Chemical Pharmaceutical is an API manufacturer based in China. It holds 32 active US drug master files and 10 valid CEPs. Its GMP standing is certified by MHRA (UK) and US FDA. Its most recent recorded inspection, by US FDA, closed on 17 November 2023 as VAI.

32
active US DMFs
10
valid CEPs
3
registered plants 1 with an FDA FEI number
1
filings across 1 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
5 of 5 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.

Inspection history

  • 17 November 2023 VAI US FDA
  • 10 March 2017 VAI US FDA
  • 7 May 2015 OAI US FDA
  • 7 June 2012 NAI US FDA
  • 24 April 2009 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Laogang Town, China Not on file
SHANGHAI, China Not on file
China, China 3006895951

What they file, and where

Molecule Regulators Docs
Lamivudine EDQM, US FDA 3
Ritonavir EDQM, US FDA 3
Atazanavir EDQM, US FDA 2
Lopinavir US FDA 2
Nevirapine EDQM, US FDA 2
Praziquantel EDQM, US FDA 2
Zidovudine EDQM, US FDA 2
Abacavir EDQM 1
Atovaquone US FDA 1
Cabotegravir US FDA 1
Show all 30 molecules on file
Canagliflozin US FDA 1
Dolutegravir US FDA 1
Dotinurad US FDA 1
Edoxaban US FDA 1
Efavirenz US FDA 1
Elagolix US FDA 1
Eltrombopag US FDA 1
Elvitegravir US FDA 1
Emtricitabine US FDA 1
Finerenone US FDA 1
Isavuconazonium US FDA 1
Lasmiditan US FDA 1
Letermovir US FDA 1
Lumefantrine US FDA 1
Omadacycline US FDA 1
Oseltamivir US FDA 1
Raltegravir EDQM 1
Rilpivirine US FDA 1
Rosuvastatin US FDA 1
Tedizolid US FDA 1

Also appears on these molecule pages

Abacavir API Atazanavir API Atovaquone API Cabotegravir API Canagliflozin API Dolutegravir API Edoxaban API Efavirenz API Elagolix API Eltrombopag API Elvitegravir API Emtricitabine API
Show 18 more molecule pages
Finerenone API Isavuconazonium API Lamivudine API Lasmiditan API Letermovir API Lopinavir API Nevirapine API Oseltamivir API Praziquantel API Raltegravir API Rilpivirine API Ritonavir API Tedizolid API Tenofovir Alafenamide API Tenofovir Disoproxil API Upadacitinib API Zidovudine API Rosuvastatin API

Filings and GMP by regulator

Regulator Filings GMP certificates
BOMRA (BW) 1 None
MHRA (UK) None 3
US FDA None 1

Questions about Shanghai Desano Chemical Pharmaceutical

Does Shanghai Desano Chemical Pharmaceutical hold a US DMF or a CEP?
Shanghai Desano Chemical Pharmaceutical holds 32 active US drug master files and 10 valid CEPs. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Is Shanghai Desano Chemical Pharmaceutical FDA-registered?
One site operated by Shanghai Desano Chemical Pharmaceutical carries an FDA establishment identifier (FEI), which means it is registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
How did Shanghai Desano Chemical Pharmaceutical's last inspection go?
The most recent inspection on record closed on 17 November 2023 as VAI (Voluntary Action Indicated: issues were found but did not warrant regulatory action). 5 inspections are on file, of which 1 closed as OAI.
Where does Shanghai Desano Chemical Pharmaceutical manufacture?
3 registered sites are on record, in China (Laogang Town, Shanghai and China). Every site is listed on this page with the register it came from.
What does Shanghai Desano Chemical Pharmaceutical make?
30 molecules are on record against Shanghai Desano Chemical Pharmaceutical, including Lamivudine, Ritonavir, Atazanavir and Lopinavir. Each links through to that molecule's full manufacturer list.
Which regulators recognise Shanghai Desano Chemical Pharmaceutical's GMP?
Current GMP certificates are on record from MHRA (UK) and US FDA. GMP recognition covers the manufacturing site, separately from any filing on the substance itself.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Shanghai Desano Chemical Pharmaceutical comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 17 November 2023.

Comparable suppliers

Matrix Pharmacorp shares 19 molecules Apitoria Pharma shares 18 molecules Hetero shares 18 molecules Cipla shares 17 molecules Laurus Labs shares 14 molecules

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates